While CSF3R mutations/variants are mainly associated with myeloid diseases, they have also been identified particularly in B-cell acute lymphoblastic leukemia (B-ALL) and multiple myeloma (MM), most likely a consequence of CSF3R expression in early hematopoietic progenitors. The gene discussed is CSF3R; the disease is plasma cell myeloma.